Malin Lindstedt
41 – 50 of 114
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Mark
Evaluation of the GARD assay in a blind cosmetics Europe study
- Contribution to journal › Article
-
Mark
The GARD platform for potency assessment of skin sensitizing chemicals
- Contribution to journal › Article
-
Mark
Clinical efficacy of a topical lactic acid bacterial microbiome in chronic rhinosinusitis: A randomized controlled trial
- Contribution to journal › Article
- 2016
-
Mark
Allergen-Specific Immunotherapy Alters the Frequency, as well as the FcR and CLR Expression Profiles of Human Dendritic Cell Subsets.
- Contribution to journal › Article
-
Mark
C-type Lectin Receptor Expression on Human Basophils and Effects of Allergen-Specific Immunotherapy
- Contribution to journal › Article
-
Mark
Effects of a honeybee lactic acid bacterial microbiome on human nasal symptoms, commensals, and biomarkers
- Contribution to journal › Article
-
Mark
From genome-wide arrays to tailor-made biomarker readout – Progress towards routine analysis of skin sensitizing chemicals with GARD
- Contribution to journal › Article
-
Mark
Selective FcγR engagement by human agonistic anti-CD40 antibodies
- Contribution to journal › Debate/Note/Editorial
- 2015
-
Mark
Prediction of Chemical Respiratory Sensitizers Using GARD, a Novel In Vitro Assay Based on a Genomic Biomarker Signature.
- Contribution to journal › Article
-
Mark
The human agonistic CD40 antibody ADC-1013 eradicates bladder tumors and generates T cell dependent tumor immunity.
- Contribution to journal › Article
